These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10222553)

  • 1. [The pathogenesis of biliary stone formation and its prevention in biliary tract diseases].
    Vakhrushev IaM; Khokhlacheva NA
    Ter Arkh; 1999; 71(2):44-8. PubMed ID: 10222553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis].
    Il'chenko AA; Drozhzhina IuV
    Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the pathogenesis and treatment of erosive gastritis and duodenitis].
    Vakhrushev IaM; Nikishina EV
    Klin Med (Mosk); 1999; 77(2):28-31. PubMed ID: 10380457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between Oddi's sphincter and bile duct pigment gallstone].
    Wu SD; Yu H; Wang HL; Su Y; Zhang ZH; Sun SL; Kong J; Tian Y; Tian Z; Wei Y; Jin HX; Jin JZ
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):58-61. PubMed ID: 17403294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of endotoxin in infected bile from patients with biliary diseases.
    Vaishnavi C; Kochhar R; Kaur S; Singh G
    Trop Gastroenterol; 2006; 27(1):22-5. PubMed ID: 16910056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenesis of liver functional disorders after cholecystectomy in cholelithiasis].
    Aksenova EM; Vakhrushev IaM
    Ter Arkh; 1999; 71(2):48-52. PubMed ID: 10222554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of praziquantel and ursodeoxycholic acid therapy on bile lithogenicity in patients with opisthorchosis on the background of main variant of standard diet].
    Korkin AL
    Vopr Pitan; 2009; 78(2):63-6. PubMed ID: 19514346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis, etiology and medical treatment of biliary lithiasis].
    Vaur JL
    Infirm Fr; 1980 May; (215):23-31. PubMed ID: 6900588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current studies of the clinical aspects and drug therapy of biliary calculosis in the elderly].
    Palleschi M; Marci M
    Clin Ter; 1981 May; 97(4):411-8. PubMed ID: 7018822
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a hydrocholeretic agent (Zanchol) on biliary lipids in post cholecystectomy patients.
    Zimmon DS; Kerner MB; Aaron MB; Raicht RF; Mosbach EH; Kessler RE
    Gastroenterology; 1976 Apr; 70(4):640-3. PubMed ID: 1254153
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
    Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid composition of blood serum and bile in biliary diseases in patients with diabetes mellitus].
    Tsukanov VV; Selivestrova EV; Dogadin SA
    Ter Arkh; 2005; 77(2):15-8. PubMed ID: 15807443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correction of disorders of bile lipid-mineral composition as a method of preventing cholelithiasis].
    Lukash NV; Krutikov SN; Feniotu GA; Serbest AR
    Vrach Delo; 1989 Aug; (8):79-81. PubMed ID: 2588541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bile duct diseases. Dyskinesias. Chronic inflammation].
    Pontes JF; Tacla M
    Arq Gastroenterol; 1981; 18(4):156-61. PubMed ID: 6751300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results on the action of dihydroxydibutylether on the lithogenic index of patients with calculosis of the gall-bladder.
    Missale G; Camarri E; Fici F; Agosti A; Mordini M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):42-3. PubMed ID: 7364531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observations on the therapeutic activity of the preparation mendiaxon in diseases of the biliary tract].
    Ivanov S; Matinheva R; Kostova N
    Vutr Boles; 1982; 21(3):17-21. PubMed ID: 7113181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases.
    Kumar R; Sharma BC; Singh J; Sarin SK
    J Gastroenterol Hepatol; 2004 Sep; 19(9):994-7. PubMed ID: 15304115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern approaches to the treatment of biliary pathology in young patients with obesity].
    Khismatullina GIa; Volevach LV; Khakamova GA; Uliamaeva VV; Bychenkova MA
    Eksp Klin Gastroenterol; 2012; (4):60-5. PubMed ID: 23402156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.